ES2148332T3 - Procedimiento para la produccion de concentrado de inmunoglobulinas g. - Google Patents
Procedimiento para la produccion de concentrado de inmunoglobulinas g.Info
- Publication number
- ES2148332T3 ES2148332T3 ES94918916T ES94918916T ES2148332T3 ES 2148332 T3 ES2148332 T3 ES 2148332T3 ES 94918916 T ES94918916 T ES 94918916T ES 94918916 T ES94918916 T ES 94918916T ES 2148332 T3 ES2148332 T3 ES 2148332T3
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- production
- concentrate
- immunoglobulin concentrate
- immunoglobulins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
LA INVENCION SE REFIERE A UN CONCENTRADO DE INMUNOGLOBULINAS G DE ORIGEN PLASMATICO Y AL PROCEDIMIENTO PARA SU PRODUCCION. ESTE PROCEDIMIENTO COMPRENDE UNA SUCESION DE SEPARACIONES CROMATOGRAFICAS, PERO NO PRECIPITACION DE ETANOL. EL PROCEDIMIENTO, COMPRENDE, ADEMAS, UN TRATAMIENTO DE INACTIVACION DEL VIRUS. LA INVENCION TAMBIEN SE REFIERE AL CONCENTRADO DE INMUNOGLOBULINAS G OBTENIDO POR EL CITADO PROCEDIMIENTO Y CUYA CALIDAD ES APROPIADA PARA TODO TIPO DE USOS TERAPEUTICOS, Y EN CONCRETO, PARA INYECCION POR VIA INTRAVENOSA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9307128A FR2706466B1 (fr) | 1993-06-14 | 1993-06-14 | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2148332T3 true ES2148332T3 (es) | 2000-10-16 |
Family
ID=9448094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94918916T Expired - Lifetime ES2148332T3 (es) | 1993-06-14 | 1994-06-13 | Procedimiento para la produccion de concentrado de inmunoglobulinas g. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6069236A (es) |
| EP (1) | EP0703922B1 (es) |
| JP (1) | JP4218980B2 (es) |
| AT (1) | ATE193020T1 (es) |
| AU (1) | AU7002394A (es) |
| BR (1) | BR9406814A (es) |
| CA (1) | CA2165203C (es) |
| CZ (1) | CZ287186B6 (es) |
| DE (1) | DE69424545T2 (es) |
| DK (1) | DK0703922T3 (es) |
| ES (1) | ES2148332T3 (es) |
| FR (1) | FR2706466B1 (es) |
| GR (1) | GR3034177T3 (es) |
| HU (1) | HU218463B (es) |
| PT (1) | PT703922E (es) |
| WO (1) | WO1994029334A1 (es) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2270044T3 (en) * | 1998-06-09 | 2015-01-26 | Csl Behring Ag | Liquid immunoglobulin G (IgG) product |
| ID27417A (id) * | 1998-06-09 | 2001-04-05 | Statens Seruminstitut | Proses untuk memproduksi immunoglobulin untuk pemberian melalui intravena dan produk-produk immunoglobulin lainnya |
| US6962700B1 (en) | 2000-09-13 | 2005-11-08 | Atopix Pharmaceuticals Corporation | Method of manufacturing immune globulin |
| FR2824568B1 (fr) * | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
| US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
| US7932365B2 (en) | 2003-11-08 | 2011-04-26 | Pro Thera Biologics, Llc | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| EP1532983A1 (en) | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Immunoglobulin preparations having increased stability |
| TWI391399B (zh) | 2005-05-25 | 2013-04-01 | 赫孚孟拉羅股份公司 | 測定溶離多肽之鹽濃度之方法 |
| FR2895263B1 (fr) | 2005-12-26 | 2008-05-30 | Lab Francais Du Fractionnement | Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives |
| WO2007136327A1 (en) * | 2006-05-22 | 2007-11-29 | Ge Healthcare Bio-Sciences Ab | A method of producing igg |
| TWI489994B (zh) | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
| JP5793076B2 (ja) | 2008-05-28 | 2015-10-14 | プロセラ バイオロジクス, インコーポレイテッド | 血液由来インター−アルファ−阻害タンパク質の調製及び組成物。 |
| FR2939667B1 (fr) | 2008-12-17 | 2012-01-27 | Fractionnement Et Des Biotechonologies Lab Franc | Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo |
| US8546548B2 (en) | 2009-05-27 | 2013-10-01 | Baxter International Inc. | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| US20100322943A1 (en) | 2009-06-17 | 2010-12-23 | Thomas Cantor | Therapeutic and diagnostic affinity purified specific polyclonal antibodies |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| PT2477603E (pt) | 2009-09-17 | 2016-06-16 | Baxalta Inc | Co-formulação estável de hialuronidase e imunoglobulina e métodos para a sua utilização |
| IT1397061B1 (it) | 2009-12-28 | 2012-12-28 | Kedrion Spa | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. |
| DK2531218T3 (en) | 2010-02-04 | 2019-04-01 | Csl Behring Ag | immunoglobulin |
| EP2361636A1 (en) | 2010-02-26 | 2011-08-31 | CSL Behring AG | Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| RU2649363C2 (ru) | 2010-11-16 | 2018-04-02 | Октафарма Аг | СПОСОБЫ СНИЖЕНИЯ И/ИЛИ УДАЛЕНИЯ FXI и FXIa ИЗ РАСТВОРОВ, СОДЕРЖАЩИХ УКАЗАННЫЕ ФАКТОРЫ СВЕРТЫВАНИЯ |
| AU2011350895B2 (en) | 2010-12-30 | 2015-05-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Glycols as pathogen inactivating agents |
| FR2974301B1 (fr) | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes |
| ES2647925T3 (es) * | 2011-05-12 | 2017-12-27 | Csl Behring Gmbh | Métodos para reducir los eventos adversos causados por preparados farmacéuticos que comprenden proteínas derivadas del plasma |
| FR2977893B1 (fr) | 2011-07-11 | 2015-02-20 | Lab Francais Du Fractionnement | Procede de preparation d'un concentre d'immunoglobulines polyvalentes |
| CA2846599A1 (en) | 2011-08-26 | 2013-03-07 | Baxter International Inc. | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之i-iv-1部分沉澱 |
| FI3590960T3 (fi) | 2012-02-29 | 2023-04-25 | Takeda Pharmaceuticals Co | Perifeeristen hermojen IgG-stimuloitu remyelinaatio |
| EP2636681A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Process for enriching IgA |
| EP2636684A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
| CN104254542A (zh) | 2012-03-09 | 2014-12-31 | 瑞士杰特贝林生物制品有限公司 | 包含分泌-样免疫球蛋白的组合物 |
| US9572872B2 (en) | 2012-09-09 | 2017-02-21 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
| US20140206844A1 (en) * | 2013-01-18 | 2014-07-24 | Prothera Biologics | Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material |
| CA2916566A1 (fr) | 2013-07-05 | 2015-01-08 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Matrice de chromatographie d'affinite |
| US9663553B2 (en) | 2014-01-29 | 2017-05-30 | Hemarus Therapeutics Limited | Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma |
| FR3018450B1 (fr) | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
| KR101917196B1 (ko) * | 2014-03-11 | 2018-11-09 | 주식회사 녹십자홀딩스 | 면역글로불린의 정제방법 |
| US9556253B2 (en) * | 2014-12-02 | 2017-01-31 | Hemarus Therapeutics Limited | Process for increased yield of immunoglobulin from human plasma |
| CN121371151A (zh) | 2014-12-03 | 2026-01-23 | 瑞士杰特贝林生物制品有限公司 | 具有增加的稳定性的包含免疫球蛋白的药物产品 |
| CA3036553A1 (en) | 2016-09-13 | 2018-03-22 | Prothera Biologics, Inc. | Methods for treating pulmonary disease using inter-alpha inhibitor proteins |
| FR3064484A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Composition d'immunoglobulines utiles pour traiter des infections virales |
| FR3064485A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Traitement d'une infection par le virus respiratoire syncytial |
| FR3064486A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures |
| KR102587810B1 (ko) | 2017-04-25 | 2023-10-11 | 프로테라 바이오로직스, 인크. | 인터-알파 억제제 단백질을 정량화하는 방법 |
| MX2022011950A (es) | 2020-03-31 | 2022-10-21 | Takeda Pharmaceuticals Co | Metodo para producir una preparacion de inmunoglobulina a partir de plasma con reduccion del inhibidor de c-1. |
| JP2024501025A (ja) | 2020-12-28 | 2024-01-10 | プラズマ テクノロジーズ エルエルシー | 免疫グロブリンgのプロセススケールでの単離のためのシステム及び方法 |
| CA3236213A1 (en) | 2021-10-27 | 2023-05-04 | Eugene ZURLO | Compositions and methods for isolating proteins |
| KR20250161658A (ko) * | 2023-03-29 | 2025-11-17 | 체에스엘 베링 아게 | 부작용과 관련된 면역글로불린을 식별하는 방법 |
| AU2024351533A1 (en) | 2023-09-26 | 2026-03-19 | Takeda Pharmaceutical Company Limited | IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7511055A (nl) * | 1975-09-19 | 1977-03-22 | Leuven Res & Dev Vzw | Trombosetest. |
| US4136094A (en) * | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
| ES502788A0 (es) * | 1981-06-04 | 1982-04-01 | Landerlan Sa Lab | Procedimiento de preparacion de imuno globulina g nativa li-bre de actividad anticomplementaria |
| FR2543448A1 (fr) * | 1983-04-01 | 1984-10-05 | Rhone Poulenc Spec Chim | Procede de fractionnement du plasma |
| US4841024A (en) * | 1986-09-15 | 1989-06-20 | Becton Dickinson And Company | Purification of antibodies |
| DE3640513A1 (de) * | 1986-11-27 | 1988-06-09 | Biotest Pharma Gmbh | Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates |
| DE3641115A1 (de) * | 1986-12-02 | 1988-06-16 | Lentia Gmbh | Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins |
| US4806346A (en) * | 1986-12-16 | 1989-02-21 | American Home Products Corporation | Method for isolation of antigen specific immunoglobulin |
| US5118796A (en) * | 1987-12-09 | 1992-06-02 | Centocor, Incorporated | Efficient large-scale purification of immunoglobulins and derivatives |
| US5177194A (en) * | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
| DE4118912C1 (es) * | 1991-06-08 | 1992-07-02 | Biotest Pharma Gmbh, 6072 Dreieich, De |
-
1993
- 1993-06-14 FR FR9307128A patent/FR2706466B1/fr not_active Expired - Lifetime
-
1994
- 1994-06-13 EP EP94918916A patent/EP0703922B1/fr not_active Expired - Lifetime
- 1994-06-13 DK DK94918916T patent/DK0703922T3/da active
- 1994-06-13 JP JP50142495A patent/JP4218980B2/ja not_active Expired - Fee Related
- 1994-06-13 CZ CZ19953287A patent/CZ287186B6/cs not_active IP Right Cessation
- 1994-06-13 WO PCT/FR1994/000699 patent/WO1994029334A1/fr not_active Ceased
- 1994-06-13 HU HU9503557A patent/HU218463B/hu not_active IP Right Cessation
- 1994-06-13 DE DE69424545T patent/DE69424545T2/de not_active Expired - Lifetime
- 1994-06-13 AT AT94918916T patent/ATE193020T1/de active
- 1994-06-13 ES ES94918916T patent/ES2148332T3/es not_active Expired - Lifetime
- 1994-06-13 CA CA002165203A patent/CA2165203C/fr not_active Expired - Fee Related
- 1994-06-13 US US08/564,030 patent/US6069236A/en not_active Expired - Lifetime
- 1994-06-13 PT PT94918916T patent/PT703922E/pt unknown
- 1994-06-13 AU AU70023/94A patent/AU7002394A/en not_active Abandoned
- 1994-06-13 BR BR9406814-3A patent/BR9406814A/pt not_active Application Discontinuation
-
2000
- 2000-08-10 GR GR20000401872T patent/GR3034177T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2706466A1 (fr) | 1994-12-23 |
| EP0703922A1 (fr) | 1996-04-03 |
| PT703922E (pt) | 2000-11-30 |
| DE69424545T2 (de) | 2001-01-18 |
| HU9503557D0 (en) | 1996-02-28 |
| US6069236A (en) | 2000-05-30 |
| HU218463B (hu) | 2000-09-28 |
| HUT74272A (en) | 1996-11-28 |
| CA2165203C (fr) | 2009-08-18 |
| WO1994029334A1 (fr) | 1994-12-22 |
| AU7002394A (en) | 1995-01-03 |
| JP4218980B2 (ja) | 2009-02-04 |
| DE69424545D1 (de) | 2000-06-21 |
| BR9406814A (pt) | 2000-05-30 |
| JPH09500369A (ja) | 1997-01-14 |
| CZ328795A3 (en) | 1996-07-17 |
| GR3034177T3 (en) | 2000-11-30 |
| DK0703922T3 (da) | 2000-11-13 |
| CZ287186B6 (en) | 2000-10-11 |
| FR2706466B1 (fr) | 1995-08-25 |
| EP0703922B1 (fr) | 2000-05-17 |
| CA2165203A1 (fr) | 1994-12-22 |
| ATE193020T1 (de) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0703922T3 (da) | Fremgangsmåde til fremstilling af immunoglobulin G koncentrat | |
| DK0414275T3 (da) | Fremgangsmåde til fremtilling af cycliske aminosyrederivater samt mellemprodukter | |
| DE3888186D1 (de) | Modulärer zusammenbau von antikörpergenen, dadurch hergestellte antikörper und deren anwendung. | |
| ES2087156T3 (es) | Metodos para la inactivacion de virus en composiciones farmaceuticas contaminadas por virus. | |
| DK0626861T4 (da) | Behandling af astma. | |
| ATE439381T1 (de) | Reinigung von polyreaktiven autoantikörpern und deren verwendungen | |
| DK0567448T3 (da) | Fremgangsmåde til fremstilling af faktor VIII | |
| DE69121502D1 (de) | Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür | |
| ATE11547T1 (de) | Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit. | |
| DK241287A (da) | Anvendelse af glutamin til fremstilling af et laegemiddel til behandling af kataboliske forstyrrelser | |
| FI902843A0 (fi) | Foerfarande foer framstaellning av renade albuminloesningar. | |
| DK0493446T3 (da) | Behandling af autoimmunsygdom. | |
| BR9807598A (pt) | Processo de produção para globulina de soro imunológico intravenoso e produto resultante | |
| ES2153842T3 (es) | Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central. | |
| ATE151774T1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen | |
| BR0011648A (pt) | Método de fabricação de imunoglobulina intravenosa e produto resultante | |
| HUT56559A (en) | Process for producing ascorbinic acid derivatives and pharma | |
| IT1258788B (it) | Derivati solforati di acidi biliari | |
| ES2183843T3 (es) | Compuestos triciclicos que tienen afinidad por el receptor 5-ht1a. | |
| ES2093912T3 (es) | Procedimiento para la depuracion de 1,1-dicloro-1-fluoroetano. | |
| DE69300409D1 (de) | Pharmazeutische Zusammensetzung mit antiviraler und antibakterieller Wirkung. | |
| UA11155A (uk) | Спосіб одержаhhя аhтирабічhого імуhоглобуліhу | |
| IT9019882A0 (it) | Composizioni farmaceutiche comprendenti derivati del glicerolo-5- fosfato atte al trattamento di patologie del sistema nervoso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 703922 Country of ref document: ES |